Amphion Innovations

Amphion Innovations is a principal investment firm specializing in early-stage medical, life sciences, and technology companies.

Business Model:

Revenue: $11.9M

Employees: 2-10

Rankings

Detailed Amphion Innovations Information

Geographic Data

Amphion Innovations headquarters map

Address: 4 Lombard Street

City: Greater London

State: england

Zip: EC3V 9HD

Country: GB

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Amphion Innovations plc is a principal investment firm specializing in both public and private early stage investments and spun out of universities and corporations. It does not invest in “speculative” technologies requiring long development timeframes or excessive capital investment. It invests in the medical, life sciences, and technology sectors with defensible core intellectual property, know-how and growth potential in very large markets of at least $1 billion in size together with corporations, governments, universities, and entrepreneurs. The firm typically invests in companies with broad-based, proprietary, platform technologies in the areas of pharmacogenomics, proteomics, nutriceuticals or wellness, diagnostics, medical products and related fields, leveraging advances in and the convergence of materials science and life science IT, particularly software technologies. It targets investments in companies based in both the United States and United Kingdom. The firm makes investments in a company that requires capital of up to $5 million as new capital in the first one to two years, with later, additional capital requirements of between $15 million and $25 million and is at least $1 billion in size. It acts as a lead investor and seeks to acquire a sizable ownership stake and measure of influence or control in its portfolio companies. The firm makes investments in the form of preferred stock or convertible debt or leverages through the ownership of stock warrants and stock options. It may reduce its shareholdings by between 10 percent and 20 percent through the introduction of additional investors in further rounds, sale or distribution of shares following a flotation, or trade sale of the entire company. The firm may also continue to invest at the initial public offering and beyond. It does not invest in speculative technologies requiring long development timeframes or excessive capital investment. Amphion Innovations plc was founded in 1984 and is based in Douglas, United Kingdom with additional offices in London, United Kingdom and New York, New York.

Contact Phone:
+12122106282

Contact Email:

Amphion Innovations went public on 9/2/2005 on the LSE

Listed Exchange:
LSE

IPO Date:
9/2/2005

Ticker Symbol:
AMP

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
10/2007 WellGen Series C 9.5M
9/2001 AgentArts Venture Round -
3/2010 Kromek Series D 0
4/2007 Motif BioSciences Series C 0
2/2006 WellGen Series B 3M
7/2003 FireStar Software Series C 0
9/2005 Kromek Series A 0
8/2006 FireStar Software Venture Round 0
3/2004 WellGen Venture Round 3M
3/2006 Motif BioSciences Venture Round 0
3/2010 Kromek Series D 0
10/2007 WellGen Series C 0
4/2007 Motif BioSciences Series C 0
8/2006 FireStar Software Venture Round 0
3/2006 Motif BioSciences Venture Round 0
2/2006 WellGen Series B 0
9/2005 Kromek Series A 0
3/2004 WellGen Venture Round 0
7/2003 FireStar Software Series C 0
9/2001 AgentArts Venture Round -

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research